Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.39 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.39 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 2/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL27829853 | 0.93 | DNM1 (0.50) | EPHX1APPDNM1MEN1KMT2A | |
| Octadecylamine SCHEMBL6930485 | 0.91 | DNM1 (0.54) | EPHX1DNM1MEN1KMT2AALDH1A1 | |
| Trifluoromethanesulfonic Acid SCHEMBL8184072 | 0.88 | EPHX1 (0.39) | EPHX1APPALDH1A1TP53CES1 | |
| Trifluoromethanesulfonic Acid SCHEMBL3129636 | 0.85 | EPHX1 (0.56) | EPHX1MEN1KMT2ACES1CES2 | |
| Trifluoromethanesulfonic Acid SCHEMBL31222713 | 0.83 | EPHX1 (0.59) | EPHX1MEN1KMT2ACES1CES2 | |
| Octane SCHEMBL8472525 | 0.83 | EPHX1 (0.59) | EPHX1MEN1KMT2ACES1CES2 | |
| Trifluoromethanesulfonic Acid SCHEMBL31657029 | 0.83 | APP (0.46) | APPDNM1MEN1KMT2AALDH1A1 | |
| Octane SCHEMBL7473071 | 0.83 | EPHX1 (0.59) | EPHX1MEN1KMT2ACES1CES2 | |
| Diaminooctane SCHEMBL31657030 | 0.83 | APP (0.46) | APPDNM1MEN1KMT2AALDH1A1 | |
| Trifluoromethanesulfonic Acid SCHEMBL31656983 | 0.83 | APP (0.46) | APPDNM1MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119530825-A | Method for constructing plane chirality [2,2] pair-ring tomato by cobalt catalysis asymmetric hydrocarbon bond activation-dynamic resolution | 浙江大学 | 2025-02-28 | — | — | CN | claimed |
| US-9024079-B2 | Separation of isomeric menthol compounds | LANXESS DEUTSCHLAND GMBH (US) | 2015-05-05 | — | — | US | claimed |
| EP-2450334-B1 | Method for separating isomeric menthol compounds | LANXESS DEUTSCHLAND GMBH (DE) | 2014-06-11 | — | — | EP | claimed |
| US-20140018580-A1 | Separation of isomeric menthol compounds | LANXESS DEUTSCHLAND GMBH (DE) | 2014-01-16 | — | — | US | claimed |
| EP-2450334-A1 | Method for separating isomeric menthol compounds | LANXESS Deutschland GmbH (DE) | 2012-05-09 | — | — | EP | claimed |
| CN-119530825-A | Method for constructing plane chirality [2,2] pair-ring tomato by cobalt catalysis asymmetric hydrocarbon bond activation-dynamic resolution | 浙江大学 | 2025-02-28 | — | — | CN | disclosed |
| EP-3292578-A1 | ELECTROCHEMICAL HYDROGEN STORAGE ELECTRODES AND CELLS | BASF Corporation (US) | 2018-03-14 | — | — | EP | disclosed |
| US-9024079-B2 | Separation of isomeric menthol compounds | LANXESS DEUTSCHLAND GMBH (US) | 2015-05-05 | — | — | US | disclosed |
| EP-2450334-B1 | Method for separating isomeric menthol compounds | LANXESS DEUTSCHLAND GMBH (DE) | 2014-06-11 | — | — | EP | disclosed |
| US-20140018580-A1 | Separation of isomeric menthol compounds | LANXESS DEUTSCHLAND GMBH (DE) | 2014-01-16 | — | — | US | disclosed |
| EP-2450334-A1 | Method for separating isomeric menthol compounds | LANXESS Deutschland GmbH (DE) | 2012-05-09 | — | — | EP | disclosed |
| WO-2009007259-A1 | PROCESS FOR THE PREPARATION OF AN INDOLE DERIVATIVE | F. HOFFMANN-LA ROCHE AG (CH) | 2009-01-15 | — | — | WO | disclosed |
| CN-1245664-C | Radiation-sensitive composition changing in refractive index and method of changing refractive index | JSR CORP (JP) | 2006-03-15 | — | — | CN | disclosed |
| CN-1174971-C | Morpholino ethers | 葛兰素惠尔康有限公司 | 2004-11-10 | — | — | CN | disclosed |
| CN-1479769-A | Radiation-sensitive refractive index-changeable composition and refractive index changing method | ������ʱ����ʽ���� | 2004-03-03 | — | — | CN | disclosed |
| CN-1309651-A | Morpholine ethers | GLAXO WELLCOME SA (ES) | 2001-08-22 | — | — | CN | disclosed |
| EP-0991693-A1 | BIPHASIC POLYMERIZATION PROCESS | Integra Lifesciences I, Ltd. (US) | 2000-04-12 | — | — | EP | disclosed |
| WO-1999000442-A1 | BIPHASIC POLYMERIZATION PROCESS | INTEGRA LIFESCIENCES I, LTD. (US) | 1999-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140018580-A1 | Separation of isomeric menthol compounds | CHRM5, TRPM5, TRPM2 | EPHX1 1157/4885APP 2436/4885DNM1 2319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.